MPH MD - Anteris Technologies Chief Board
Insider
MPH MD is Chief Board of Anteris Technologies
| Phone | 61 13 0055 0310 |
| Web | https://www.anteristech.com |
Anteris Technologies Management Efficiency
The company has return on total asset (ROA) of (0.8433) % which means that it has lost $0.8433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5517) %, meaning that it generated substantial loss on money invested by shareholders. Anteris Technologies' management efficiency ratios could be used to measure how well Anteris Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Anteris Technologies has accumulated 4.07 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. Anteris Technologies has a current ratio of 4.22, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Anteris Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Anteris Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Anteris Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Anteris to invest in growth at high rates of return. When we think about Anteris Technologies' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Broderick | Brain Scientific | N/A | |
| Lotta Bus | BICO Group AB | 53 | |
| Richard Ginn | Tenon Medical | 59 | |
| Artur Aira | Cellink AB | 56 | |
| Erica Bell | BICO Group AB | 50 | |
| Asa Hillsten | Cellink AB | 48 | |
| Jason Clifton | Cellink AB | N/A | |
| Vadim Sakharov | Brain Scientific | 49 | |
| Farid Anthony | Brain Scientific | 41 | |
| Erik Gatenholm | BICO Group AB | 34 | |
| Stuart Bernstein | Brain Scientific | N/A | |
| Hassan Kotob | Brain Scientific | 59 | |
| Niclas Emanuelsson | BICO Group AB | 52 | |
| Itedale Redwan | BICO Group AB | N/A | |
| Jason Clifton | BICO Group AB | N/A | |
| Artur Aira | BICO Group AB | 56 | |
| BonnieJeanne Gerety | Brain Scientific | 61 | |
| David Meyer | Aurora Spine | N/A | |
| Laszlo Garamszegi | Aurora Spine | 52 | |
| Erik Gatenholm | Cellink AB | 34 | |
| Irina Nazarova | Brain Scientific | N/A | |
Management Performance
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 |
Anteris Technologies Leadership Team
Elected by the shareholders, the Anteris Technologies' board of directors comprises two types of representatives: Anteris Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anteris. The board's role is to monitor Anteris Technologies' management team and ensure that shareholders' interests are well served. Anteris Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anteris Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| AC FAA, Exec | ||
| Wayne Paterson, Non-Executive Independent Director | ||
| Matthew McDonnell, Chief Officer | ||
| David Denis, Chief Officer | ||
| Stephen Denaro, Independent Sec | ||
| Chris Olig, Bus Director | ||
| Danny Zanardo, Commercial International | ||
| MPH MD, Chief Board |
Anteris Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Anteris Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 | |||
| Operating Margin | (5.05) % | |||
| Current Valuation | 196.49 M | |||
| Shares Outstanding | 13.9 M | |||
| Shares Owned By Insiders | 13.27 % | |||
| Shares Owned By Institutions | 28.34 % | |||
| Price To Earning | (3.20) X | |||
| Price To Book | 10.09 X | |||
| Price To Sales | 30.51 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Anteris Pink Sheet
If you are still planning to invest in Anteris Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anteris Technologies' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |